Bilyana Koleva

Bilyana Koleva has a diverse work experience in the field of scientific research and development. Bilyana began their career at Dyax as a Eukaryotic Protein Expression/Antigen Expression Co-op in 2007. From 2008 to 2013, they worked at Enzymatics, starting as an Assistant Scientist I and then progressing to Assistant Scientist II. In 2017, they joined Bristol-Myers Squibb as a Process Development Analytics Graduate Intern. In 2018, they moved to Agenus and worked as a Scientist until 2020. Currently, they serve as a Senior Scientist at Dragonfly Therapeutics, Inc.

Bilyana Koleva completed their education at Northeastern University. Bilyana obtained a Bachelor's degree in Biochemistry in an unspecified year before 2008. Subsequently, they pursued a Master's degree in Chemistry, completing it in 2013. Following this, they continued their studies in Chemistry and completed a Doctor of Philosophy (PhD) degree in 2018.